Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation
- 23 July 2003
- journal article
- research article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 26 (4) , 277-282
Abstract
Compounds that activate adenylate cyclase, increasing intracellular cyclic adenosine monophosphate (cAMP), inhibit equine platelet aggregation. Cyclic AMP is broken down by phosphodiesterase (PDE) and, in the present study, the effects of theophylline, a nonselective PDE inhibitor, and selective inhibitors of PDE isoenzymes PDE3, PDE4 and PDE5, on equine platelet aggregation in response to platelet activating factor (PAF) and adenosine diphosphate (ADP) have been examined. Theophylline and the PDE3 inhibitors, trequinsin and quazinone, inhibited both PAF and ADP‐induced aggregation in a concentration dependent manner. The inhibition of PAF‐induced aggregation was, however, significantly greater than that of the response to ADP. The inhibitory effects of theophylline and the PDE3 inhibitors on ADP‐ but not PAF‐, induced aggregation were reversed by addition of the calcium ionophore, A23187. Rolipram and zaprinast, inhibitors of PDE4 and PDE5, respectively, had no effect on either PAF‐ or ADP‐induced aggregation. These results demonstrate that inhibition of aggregation caused by PAF or ADP can be achieved by selective inhibition of PDE3 but suggest that there may be agonist‐specific differences in the intracellular signalling pathways that regulate equine platelet aggregation.Keywords
This publication has 28 references indexed in Scilit:
- Effects of P2Y 1 and P2Y 12 receptor antagonists on ADP-induced shape change of equine platelets: comparison with human plateletsPlatelets, 2002
- Actions and interactions of , 5- , histamine and on equine plateletsResearch in Veterinary Science, 2000
- Characterization of the Isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021Cellular Signalling, 1996
- The inhibition of adenylate cyclase in equine platelets by collagen and by platelet-activating factorPlatelets, 1996
- Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytesClinical & Experimental Allergy, 1995
- A method for loading equine platelets with the fluorescent calcium indicator Fura-2: ADP induces a rise in the cytosolic free calcium ion concentrationEquine Veterinary Journal, 1993
- XANTHINES INHIBIT HUMAN PLATELET AGGREGATION INDUCED BY PLATELET‐ACTIVATING FACTORClinical and Experimental Pharmacology and Physiology, 1992
- Effects of WEB 2086, an antagonist to the receptor for platelet‐activating factor (PAF), on PAF‐induced responses in the horseEquine Veterinary Journal, 1992
- Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMPInflammation Research, 1984
- HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitroLife Sciences, 1982